However, simply increasing AKT may not be an adequate approach for treating sarcopenia because despite enhanced muscle size, sustained hyperactivation of AKT was reported to produce vacuolated fibers that are characteristic of late onset myopathy during mTORC1 hyperactivation. This evidence concerns the gene AKT1 and myopathy.